查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538520

免疫調節劑市場報告：2030 年趨勢、預測與競爭分析

Immunomodulator Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

免疫調節劑的趨勢與預測

預計到 2030 年，全球免疫調節劑市場將達到 2.98 億美元，2024 年至 2030 年複合年成長率為 4.6%。市場的主要促進因素是多發性硬化症盛行率的增加、患者對高效藥物的需求增加以及自體免疫疾病比例的增加。全球免疫調節劑市場的未來充滿希望，呼吸系統、腫瘤和愛滋病市場存在機會。

免疫調節劑按細分市場

本研究按產品類型、應用和地區對全球免疫調節劑進行了預測。

免疫調節劑市場洞察

Lucintel 預測，由於免疫抑制劑可治療許多自體免疫疾病，因此預計在預測期內將出現強勁成長。

在這個市場中，腫瘤學預計將在預測期內實現最高成長。

由於人口中慢性病的盛行率不斷上升以及該地區主要企業的存在，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球免疫調節劑市場預計將達到 2.98 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球免疫調節劑市場預計將以4.6%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 此市場的主要促進因素是多發性硬化症盛行率的增加、患者對高效藥物的需求增加以及自體免疫疾病比例的增加。

Q4.市場的主要細分市場是：

A4. 免疫調節劑市場前景廣闊，呼吸系統、腫瘤和愛滋病市場存在機會。

Q5.市場的主要企業是：

A5. 主要免疫調節劑公司如下：

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於免疫抑制劑具有治療自體免疫疾病的能力，預計在預測期內將出現高速成長。

Q7.未來五年預計哪些地區的市場成長最大？

A7. 由於人口中慢性病的盛行率不斷上升以及該地區主要企業的存在，北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球免疫調節劑市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球免疫調節劑市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球免疫調節劑市場
    • 免疫抑制劑
    • 免疫促效劑
  • 全球免疫調節劑市場按應用
    • 呼吸系統
    • 瘤
    • HIV
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球免疫調節劑市場區域分佈
  • 北美免疫調節劑市場
  • 歐洲免疫調節劑市場
  • 亞太免疫調節劑市場
  • 其他地區免疫調節劑市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球免疫調節劑市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球免疫調節劑市場產能擴張
    • 全球免疫調節劑市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme
簡介目錄

Immunomodulator Trends and Forecast

The future of the global immunomodulator market looks promising with opportunities in the respiratory, oncology, and HIV markets. The global immunomodulator market is expected to reach an estimated $298.0 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing multiple sclerosis incidence, rising patient need for efficient medications, and growing rates of autoimmune disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Immunomodulator by Segment

The study includes a forecast for the global immunomodulator by product type, application, and region.

Immunomodulator Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Immunosuppressants
  • Immunostimulants

Immunomodulator Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Respiratory
  • Oncology
  • HIV
  • Others

Immunomodulator Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Immunomodulator Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies immunomodulator companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immunomodulator companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme

Immunomodulator Market Insights

Lucintel forecasts that immunosuppressant is expected to witness higher growth over the forecast period due to their ability to cure a number of autoimmune illnesses.

Within this market, oncology is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to increasing prevalence of chronic diseases among population and presence of key players in the region.

Features of the Global Immunomodulator Market

Market Size Estimates: Immunomodulator market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Immunomodulator market size by product type, application, and region in terms of value ($M).

Regional Analysis: Immunomodulator market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the immunomodulator market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the immunomodulator market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the immunomodulator market size?

Answer: The global immunomodulator market is expected to reach an estimated $298.0 million by 2030.

Q2. What is the growth forecast for immunomodulator market?

Answer: The global immunomodulator market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the immunomodulator market?

Answer: The major drivers for this market are increasing multiple sclerosis incidence, rising patient need for efficient medications, and growing rates of autoimmune disorders.

Q4. What are the major segments for immunomodulator market?

Answer: The future of the immunomodulator market looks promising with opportunities in the respiratory, oncology, and HIV markets.

Q5. Who are the key immunomodulator market companies?

Answer: Some of the key immunomodulator companies are as follows:

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme

Q6. Which immunomodulator market segment will be the largest in future?

Answer: Lucintel forecasts that immunosuppressant is expected to witness higher growth over the forecast period due to their ability to cure a number of autoimmune illnesses.

Q7. In immunomodulator market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing prevalence of chronic diseases among population and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the immunomodulator market by product type (immunosuppressants and immunostimulants), application (respiratory, oncology, HIV, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immunomodulator Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Immunomodulator Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Immunomodulator Market by Product Type
    • 3.3.1: Immunosuppressants
    • 3.3.2: Immunostimulants
  • 3.4: Global Immunomodulator Market by Application
    • 3.4.1: Respiratory
    • 3.4.2: Oncology
    • 3.4.3: HIV
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Immunomodulator Market by Region
  • 4.2: North American Immunomodulator Market
    • 4.2.1: North American Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.2.2: North American Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
  • 4.3: European Immunomodulator Market
    • 4.3.1: European Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.3.2: European Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
  • 4.4: APAC Immunomodulator Market
    • 4.4.1: APAC Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.4.2: APAC Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
  • 4.5: ROW Immunomodulator Market
    • 4.5.1: ROW Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.5.2: ROW Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Immunomodulator Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Immunomodulator Market by Application
    • 6.1.3: Growth Opportunities for the Global Immunomodulator Market by Region
  • 6.2: Emerging Trends in the Global Immunomodulator Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Immunomodulator Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunomodulator Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Novartis
  • 7.3: Biogen
  • 7.4: Teva Pharmaceutical Industries
  • 7.5: Amgen
  • 7.6: Bristol-Myers & Squibb Company
  • 7.7: Merck Sharp & Dohme